dr. petrylak on combinations with pembrolizumab in urothelial carcinoma
Published 7 years ago • 62 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
0:47
dr. balar on combinations with pembrolizumab for urothelial cancer
-
0:57
dr. petrylak on the keynote-045 trial for urothelial carcinoma
-
2:03
dr. petrylak on enfortumab vedotin in locally advanced or metastatic urothelial carcinoma
-
1:40
dr. petrylak on trial of atezolizumab in urothelial carcinoma
-
1:18
dr. plimack on combo of pembrolizumab/epacodostat in bladder cancer
-
1:07
dr. petrylak on the results of the ev-103 trial in bladder cancer
-
0:50
dr. petrylak on atezolizumab in bladder cancer
-
0:58
daniel p. petrylak, md, on immunotherapy & chemotherapy combinations in metastatic bladder cancer
-
1:09
dr. plimack on frontline pembrolizumab for urothelial carcinoma
-
2:00
exploring the combination of epacadostat and pembrolizumab in urothelial carcinoma
-
0:57
dr. petrylak on immunotherapy in bladder cancer
-
1:41
dr. petrylak on immunotherapy for second-line treatment in bladder cancer
-
2:03
dr. rosenberg on enfortumab vedotin/pembrolizumab in urothelial carcinoma
-
1:01
dr. petrylak on novel immunotherapy research in bladder cancer
-
1:47
dr. petrylak on sequencing of targeted agents in bladder cancer
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
2:21
dr. galsky on maintenance pembrolizumab in urothelial cancer
-
1:18
dr. plimack on keynote-045 trial for pembrolizumab in urothelial carcinoma